Researches

Displaying 451 - 460 of 4023
# Title Department Research Year
451 Colorimetric and fluorometric nanoprobe for selective and sensitive recognition of hazardous colorant indigo carmine in beverages based on ion pairing with nitrogen doped carbon dots Department of Pharmaceutical Analytical Chemistry 2021
452 Crystal structure and quantum chemical calculations of (E)1-benzyl-3-((4-methoxyphenyl)imino)-5-methylindolin-2-one Department of Medicinal Chemistry 2021
453 Cytosolic aromatic dehydrogenase provides benzoic acid for xanthone biosynthesis in Hypericum Department of Pharmacognosy 2021
454 Design and Synthesis of (2-oxo-1,2-Dihydroquinolin-4-yl)-1,2,3-triazole Derivatives via Click Reaction: Potential Apoptotic Antiproliferative Agents Department of Pharmaceutical Organic Chemistry 2021
455 Design, synthesis and mechanistic study of new 1,2,4-triazole derivatives as antimicrobial agents 2021
456 Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV Department of Pharmaceutical Organic Chemistry 2021
457 Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors Department of Pharmaceutical Organic Chemistry 2021
458 Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile Department of Pharmaceutical Organic Chemistry 2021
459 Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity Department of Pharmaceutical Organic Chemistry 2021
460 Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4- (methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors 2021